Quit Genius partners with Evernorth to provide broader access to digital addiction solution as addiction numbers soar during Covid-19

Press Release

SAN FRANCISCO, Oct. 7, 2020 — Quit Genius, the world’s first digital clinic for multiple addictions, today announced its partnership with Evernorth, Cigna Corporation’s health services segment, to broaden access to its digital addiction solutions. As the single solution for nicotine cessation on the Evernorth Digital Health Formulary, Evernorth clients that utilize Quit Genius will have access to its digital program built on the evidence-based principles of Medication-Assisted Treatment (MAT) to improve quit rates and lower overall healthcare costs, including those exacerbated by the pandemic.

“The social isolation and stress brought on by the pandemic has increased susceptibility to substance abuse, addiction and relapse. As the world continues to navigate the realities of COVID-19, people who smoke or vape, use opioids or have other addiction issues have become part of the more vulnerable population, as direct challenges to respiratory health cause those who smoke to be particularly susceptible to infection by the coronavirus and its associated complications,” said Dr. Yusuf Sherwani, Quit Genius Co-Founder and CEO. “Being Evernorth’s digital health solution for nicotine cessation is an important step forward in helping those that struggle with addiction gain access to the solutions they need.”

“First and foremost, the Digital Health Formulary is focused on creating better individual health outcomes, which is why we offer rigorously evaluated solutions in combination with support from Express Scripts specialist pharmacists,” said Mark Bini, chief patient experience officer of Express Scripts. “The added benefit to health plans is the simplicity and affordability we offer by helping navigate the morass of more than 300,000 digital health solutions on the market today, and delivering average plan savings of more than $120,000 per digital solution in alleviated administrative burden alone.”

The Evernorth Digital Health Formulary, announced last year, allows participating employers and health plans to increase patients’ access to emerging products and technology simply and affordably. Customers who access Quit Genius via the Digital Health Formulary are able to streamline the procurement process while members will receive support from Express Scripts specialist pharmacists to ensure appropriate use of the technology.

About Pelago

Pelago, formerly Quit Genius, partners with enterprises as the leading virtual clinic for substance use management among their employees. We are transforming substance use support—from prevention to treatment—delivering education, management skills, and opportunities for positive change to members struggling with substance use, most commonly tobacco, alcohol, or opioids. Our solution gives employers the means to offer on-demand, personalized support to workers seeking to live healthier lives. Pelago’s cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) programs deliver convenient, accessible, and effective support that seamlessly integrates with health plans, pharmacy benefit managers, and wellness platforms. To date, Pelago has helped more than 750,000 members manage their substance use and improve their lives.

Say hello to brighter days together

Get started quickly. Save costs. Change lives forever.